Lincoln Capital Corp Bio Techne Corp Transaction History

Lincoln Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$353.85 - $487.79 $161,001 - $221,944	-455 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$456.15 - $525.06 $10,491 - $12,076	23 Added 5.32%	455 $235,000
Q3 2021 Oct 18, 2021	BUY	$444.87 - $538.88 $192,183 - $232,796	432 New	432 $209,000

596

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.02B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Lincoln Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln Capital Corp with notifications on news.